Document Detail

Sequential combination of two intravenous thrombolytics (recombinant tissue plasminogen activator/tenecteplase) in a patient with stroke and cardioembolic basilar artery occlusion.
MedLine Citation:
PMID:  19110148     Owner:  NLM     Status:  MEDLINE    
Stroke caused by acute occlusion of basilar artery (AOBA) produces high risk of death. In eligible patients, thrombolysis significantly reduces mortality and disability rate. In most hospitals, thrombolysis is limited to intravenous (IV) route of recombinant tissue plasminogen activator, without any therapeutic alternative in cases of treatment failure. We report a case of cardioembolic AOBA, not responsive to a conventional regimen of IV recombinant tissue plasminogen activator. A sequential combination of IV tenecteplase (0.4 mg/kg) led to a complete recanalization of basilar artery, with a very good clinical outcome. The potential for a combination of two successive IV regimens should be evaluated in AOBA.
Didier Smadja; Stéphane Olindo; Martine Saint-Vil; Nicolas Chausson
Related Documents :
23406738 - Transfemoral access for valve in valve implantation of an edwards sapien xt valve in a ...
17885248 - A cone-beam volume ct using a 3d angiography system with a flat panel detector of direc...
4071348 - Intra-arterial diazepam. a report of 2 cases.
3544028 - Pulmonary arteriography: comparison of cough stimulation effects of diatrizoate and iox...
3415588 - The martin titanline arterial clamp. a new lightweight alternative.
11477258 - Celiac-bimesenteric trunk: anatomic and radiologic description--case report.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association     Volume:  18     ISSN:  1532-8511     ISO Abbreviation:  J Stroke Cerebrovasc Dis     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-26     Completed Date:  2009-02-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111633     Medline TA:  J Stroke Cerebrovasc Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  68-71     Citation Subset:  IM    
Department of Neurology, University Hospital of Fort-de-France, Martinique, the French West Indies.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Diffusion Magnetic Resonance Imaging
Drug Therapy, Combination
Embolism / complications*,  drug therapy,  pathology
Fibrinolytic Agents / administration & dosage*
Heart Diseases / complications*,  drug therapy,  pathology
Infusions, Intravenous
Magnetic Resonance Angiography
Recombinant Proteins / administration & dosage
Stroke / drug therapy*,  etiology,  pathology
Thrombolytic Therapy*
Tissue Plasminogen Activator / administration & dosage*
Treatment Outcome
Vertebrobasilar Insufficiency / drug therapy*,  etiology,  pathology
Reg. No./Substance:
0/Fibrinolytic Agents; 0/Recombinant Proteins; 0/tenecteplase; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Locomotion outcome in hemiplegic patients with middle cerebral artery infarction: the difference bet...
Next Document:  The stroke that struck back: an unusual alien hand presentation.